(APRIL 12, 2024) UVM Cancer Center director Randall Holcombe, M.D., M.B.A., welcomed more than 75 students from five Burlington-area high schools to the second Careers in Cancer event at the UVM Cancer Center on April 12, WCAX-TV reported.

Seventy-five students from five Burlington-area high schools attended the second Careers in Cancer event at the UVM Cancer Center on April 12, receiving career advice from UVM Cancer Center leadership, faculty, staff, and trainees and observing faculty and students working on cancer research in several of the university’s research labs.

Associate Professor of Pharmacology Karen Glass, Ph.D., was recently honored with an award totaling more than $380,000 from the MCA program for her proposed project, “Application of Cryo-Electron Microscopy to Determine the Structure of Epigenetic Regulatory Complexes.” Glass is the first UVM faculty member to receive an NSF MCA award.

Larner study underscores the critical importance of COVID-19 vaccination in preventing illness from the virus.

(MARCH 6, 2024) Assistant Professor of Psychiatry Elias Klemperer, Ph.D., spoke with WCAX-TV about his recent grant to study nicotine-limiting standards across the Northeast; in particular, what works to get smokers to switch to products that use less nicotine.

(FEBRUARY 21, 2024) Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, spoke with WCAX-TV about a promising new treatment for mesothelioma that is being tested at the UVM Cancer Center.

(FEBRUARY 6, 2024) UVM Health Network President and CEO Sunny Eappen, M.D., M.B.A., and UVMHN Radiation Oncology Chair H. James Wallace, M.D., associate professor of radiology at the Larner College of Medicine, commented to the Press-Republican about a new initiative to upgrade cancer care services at network hospitals.